{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:21:15Z","timestamp":1769156475635,"version":"3.49.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.transci.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T21:45:49Z","timestamp":1504388749000},"page":"717-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Corticosteroid-induced vaso-occlusive events may be prevented by lowering hemoglobin S levels in adults with sickle cell disease"],"prefix":"10.1016","volume":"56","author":[{"given":"Mahmut","family":"Yeral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Boga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pelin","family":"Aytan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Ozdogu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.transci.2017.08.005_bib0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3324\/haematol.10800","article-title":"Steroid treatment in children with sickle-cell disease","volume":"92","author":"Couillard","year":"2007","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.transci.2017.08.005_bib0010","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood.V92.9.3082","article-title":"Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease","volume":"92","author":"Bernini","year":"1998","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.transci.2017.08.005_bib0015","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine and new research directions","volume":"84","author":"Kato","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transci.2017.08.005_bib0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM199403173301101","article-title":"High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease","volume":"330","author":"Griffin","year":"1994","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.transci.2017.08.005_bib0025","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0027-9684(15)31410-3","article-title":"Severe vaso-occlusive episodes associated with use of systemic corticosteroids in patients with sickle cell disease","volume":"100","author":"Darbari","year":"2008","journal-title":"J Natl Med Assoc"},{"issue":"5","key":"10.1016\/j.transci.2017.08.005_bib0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3324\/haematol.2013.099747","article-title":"Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel","volume":"99","author":"Angelucci","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2017.08.005_bib0035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1182\/asheducation-2010.1.416","article-title":"Evidence-based mini-review: are systemic corticosteroids an effective treatment for acute pain in sickle cell disease?","author":"Vandy Black","year":"2010","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"8","key":"10.1016\/j.transci.2017.08.005_bib0040","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0027-9684(15)31410-3","article-title":"Severe vaso-occlusive episodes associated with use of systemic corticosteroids in patients with sickle cell disease","volume":"100","author":"Darbari","year":"2008","journal-title":"J Natl Med Assoc"},{"issue":"3","key":"10.1016\/j.transci.2017.08.005_bib0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.transci.2010.09.015","article-title":"Alteration of alterations of circulating endothelial cells after apheresis in patients with sickle cell disease: a potential clue for restoration of pathophysiology","volume":"43","author":"Boga","year":"2010","journal-title":"Transfus Apher Sci"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050217301568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050217301568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T23:54:25Z","timestamp":1602892465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050217301568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1473050217301568"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2017.08.005","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corticosteroid-induced vaso-occlusive events may be prevented by lowering hemoglobin S levels in adults with sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}